LGC Capital’s leading Australian medical cannabis LP partner, Little Green Pharma, commences commercial sales to …

/NOT FOR DISTRIBUTION IN THE UNITED STATES/

  • Little Green Pharma successfully completes second commercial medical cannabis harvest and commences sales to Australian patients.
  • LGP’s products accepted into major statewide clinical trials for advanced cancer.
  • LGP commences negotiations for exports to Germany.
  • LGP negotiating to build a 400,000 square foot facility on a 500,000 square foot site.

MONTREAL, Oct. 5, 2018 /CNW Telbec/ – LGC Capital Ltd. (TSXV:LG) (“LGC”) is pleased to advise that Australian medical cannabis company Little Green Pharma (LGP) in which LGC has a 14.21% interest, has successfully completed harvest of its second commercial medical cannabis crop from its facility south of Perth in Western Australia.

Logo: LGC Capital Ltd (CNW Group/LGC Capital Ltd)

This quarter, LGP successfully achieved another milestone having produced Australia’s first locally grown medicinal cannabis product as well

... read more at: https://www.benzinga.com/pressreleases/18/10/r12463699/lgc-capitals-leading-australian-medical-cannabis-lp-partner-little-gre

by